Cargando…

The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer

Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are highly dependent on nutrients in order to duplicate their cell mass during each cell division. In particular, essential amino acids are indispensable for proliferating cancer cells. Their uptake across t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Häfliger, Pascal, Charles, Roch-Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566973/ https://www.ncbi.nlm.nih.gov/pubmed/31100853 http://dx.doi.org/10.3390/ijms20102428

Ejemplares similares

The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer
por: Salisbury, Travis B, et al.
Publicado: (2018)

The L-type Amino Acid Transporter (LAT1) Expression in Patients with Scoliosis
por: Demura, Satoru, et al.
Publicado: (2021)

Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer
por: Shindo, Haruhiko, et al.
Publicado: (2021)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET
por: Ikotun, Oluwatayo F., et al.
Publicado: (2013)

Positive Regulation of Decidualization by l-Type Amino Acid Transporter 1 (lat1) in Pregnant Mice
por: Wang, Xiaojie, et al.
Publicado: (2016)

Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia
por: Jia, Xiaotong, et al.
Publicado: (2022)

l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019)

L-type amino acid transporter (LAT) 1 expression in (18)F-FET-negative gliomas
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands
por: Huttunen, Johanna, et al.
Publicado: (2021)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

Characterisation of L-Type Amino Acid Transporter 1 (LAT1) Expression in Human Skeletal Muscle by Immunofluorescent Microscopy
por: Hodson, Nathan, et al.
Publicado: (2017)

Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma Cells
por: Srisongkram, Tarapong, et al.
Publicado: (2019)

The Evaluation of l‐Tryptophan Derivatives as Inhibitors of the l‐Type Amino Acid Transporter LAT1 (SLC7A5)
por: Graff, Julien, et al.
Publicado: (2022)

The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model
por: Häfliger, Pascal, et al.
Publicado: (2018)

Anti‐tumor effects of mAb against l‐type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes
por: Ueda, Shiho, et al.
Publicado: (2019)

Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain
por: Hugele, Agathe, et al.
Publicado: (2022)

Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno‐foetal amino acid transport
por: Zaugg, Jonas, et al.
Publicado: (2020)

Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma
por: Srisongkram, Tarapong, et al.
Publicado: (2022)

Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1)
por: Singh, Natesh, et al.
Publicado: (2019)

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma
por: Cormerais, Yann, et al.
Publicado: (2019)

Dysfunctional LAT2 Amino Acid Transporter Is Associated With Cataract in Mouse and Humans
por: Knöpfel, Emilia Boiadjieva, et al.
Publicado: (2019)

Plasma citrulline correlates with basolateral amino acid transporter LAT4 expression in human small intestine
por: Maric, Stefano, et al.
Publicado: (2021)

Monoterpene Glycoside ESK246 from Pittosporum Targets LAT3 Amino Acid Transport and Prostate Cancer Cell Growth
por: Wang, Qian, et al.
Publicado: (2014)

Ubiquitylation and endocytosis of the human LAT1/SLC7A5 amino acid transporter
por: Barthelemy, Céline, et al.
Publicado: (2019)

L-Type Amino Acid Transporter 1 (LAT1) Promotes PMA-Induced Cell Migration through mTORC2 Activation at the Lysosome
por: Tae, Kun, et al.
Publicado: (2023)

Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter
por: Yan, Renhong, et al.
Publicado: (2021)

Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1
por: Singh, Natesh, et al.
Publicado: (2018)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

Endotoxin-induced inflammation down-regulates l-type amino acid transporter 1 (LAT1) expression at the blood–brain barrier of male rats and mice
por: Wittmann, Gábor, et al.
Publicado: (2015)

Tyrosine–Chlorambucil Conjugates Facilitate Cellular Uptake through L-Type Amino Acid Transporter 1 (LAT1) in Human Breast Cancer Cell Line MCF-7
por: Pocasap, Piman, et al.
Publicado: (2020)

Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods
por: Singh, Natesh, et al.
Publicado: (2018)

The association between the amino acid transporter LAT1, tumor immunometabolic and proliferative features and menopausal status in breast cancer
por: Ramshankar, Gautham, et al.
Publicado: (2023)

Amino acid transporters as emerging therapeutic targets in cancer
por: Saito, Yasuhiro, et al.
Publicado: (2021)

Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020)

L-Type amino acid transporter 1 as a target for drug delivery
por: Puris, Elena, et al.
Publicado: (2020)

Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B(0)AT2 and y(+)LAT1 functional cooperation
por: Taslimifar, Mehdi, et al.
Publicado: (2021)

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
por: Toyoda, M, et al.
Publicado: (2014)

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6rlnq7o3akqvhc6am6a3o3mgha